Medications

Latest obesity drug not cost-effective for adolescents

Among today's obesity drugs, Wegovy (semaglutide) produces the greatest weight loss in teenagers, but a study by Columbia researchers has found that the trendy obesity drug is not cost-effective at its current price.

Medications

Paxlovid soon will not be free for Americans

The antiviral Paxlovid has kept patients from becoming severely ill and dying from COVID-19 since it became available—at no cost to them. But by the middle of next year, the U.S. government will stop subsidizing the medication. ...

Alzheimer's disease & dementia

Controversial Alzheimer's drug approval sparks surprising impact

When the U.S. Food and Drug Administration gave controversial accelerated approval to the first Alzheimer's drug in nearly 20 years, it had a surprising impact on attitudes about research into the disease. A survey by University ...

page 2 from 11